- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
SMS Pharmaceuticals has announced a board meeting to discuss key compliance matters. They have submitted a certificate confirming actions taken under SEBI regulations regarding the dematerialization of securities for the quarter ending 31st December 2024. This assurance reflects the company's adherence to operational protocols, which may bolster investor confidence in its governance practices. The ongoing commitment to regulatory compliance may present a positive outlook for investors, indicating a focus on maintaining operational integrity and enhancing share liquidity.